Insulate your heart from cardiac diseases with Helicobacter Pyroli vaccine CTB-UE: CTB-UE vaccine-based Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: CTB-UE vaccine ncreases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes via down-regulation of its target gene, 28/July/2018, 7.52 pm

Reproductive hormone-based therapy for blood sugar disease:  FSH(Follicle stimulating hormone) increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 28/June/2018, 7.05 pm
July 28, 2018
A sweet way to lengthen lifespan (too good to be true): Polysaccharide-based therapy for aging-associated diseases and Lifespan extension: Astragalus polysaccharide, a polysaccharide isolated from mushroom astragalus membraneous, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging, via down-regulation of its target gene, 28/July/2018, 10.48 pm
July 28, 2018
Show all

Introduction: What they say

A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was published, in the 6 April  2015 issue of the journal “Nature cell biology” (the number 1 journal in “Cell biology” research with an impact factor of 20.761)by Prof Tzahor E, D’Uva E, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Insulate your heart from cardiac diseases with Helicobacter Pyroli vaccine CTB-UE: CTB-UE vaccine-based Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: CTB-UE vaccine ncreases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes via down-regulation of its target gene


From significance of the study to Public health relevance: 

Given that: (1)  cardiovascular disease is the leading cause of death worldwide; (2) the raise of death rate, due to cardiovascular disease, has increased from  123 lakhs in 1990 to 173 lakhs in 2013; (3) 85% of people over 80 years are susceptible to cardiovascular diseases;(4) in India, in 2004, 14.6 lakhs deaths (14% of total deaths) were due to ischemic heart disease; (3) the death due to cardiovascular disease is higher in low-to-middle income countries compared to developed countries; (4) the global economic cost spent in the treatment of cardiovascular disease in 2011 was little more than 10 billion US dollars; (5) an alarming number of people, such as 230 lakhs people, will die from cardiovascular diseases each year by 2030, there is an urgent need to find: (i) a way to induce regeneration of cardiomyocytes that were lost in Myocardial patients; (ii) a cheaper alternative to the existing expensive drugsand (iv) a side-effect-free Natural product-based drug.


From research findings to Therapeutic opportunity: 

This study suggests, first the first time, Helicobacter Pyroli vaccine CTB-UE-based therapy, with detailed mechanistic insights, for inducing cardiomyocyte dedifferentiation, proliferation and regeneration.

CTB-UE vaccine, which contains mucosal adjuvant cholera toxin B subunit (CTB) and five cell epitopes from the H. pylori urease subunits,, has been shown to be effective in controlling infections caused by H. pylori. However, the mechanism of action remains largely unknown.

This study suggests that CTB-UE vaccine, by increasing the expression of its target gene, it may: (1) increase ERBB2/Her2 expression; (2) induce cardiomyocyte (CM) dedifferentiation and proliferation; and (3) cardiomyocyte (CM) redifferentiation and regeneration(fig.1). Thus, CTB-UE vaccine, either alone or in combination with other drugs, may be used to treat cardiac dysfunction. 

Figure1. Mechanistic insights into how CTB-UE vaccine may promote cardiac dedifferentiation and regeneration. CTB-UE vaccine, by increasing the expression of its target gene, it may upregulate the expression of ERRB2/HER2 and promote cardiac dedifferentiation and regeneration

Figure 2. The CTB-UE vaccine may promote cardiac regeneration through induction of Her2/Erbb2

 

 

 

 

 

 

 

 

 

Given the mechanistic basis of how CTB-UE vaccine  may aid in cardiomyocyte survival and regeneration,  medical practitioners and cardiologists may consider vaccinating myocardial patients with the CTB-UE vaccine, as it may not only aid in cardiomyocyte regeneration following myocardial infarction but also protect against myocardial diseases (fig.2).  

[easy_payment currency=”USD”]


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $ 500#

Undisclosed (mechanistic insights) information: How Helicobacter Pyroli vaccine CTB-UE increases the expression of  ERBB2/Her2

For purchase and payment details, you may reach us at admin@genomediscovery.org

# Research cooperation


References: 

Web: http://genomediscovery.org or newbioideas.com

Citation: Boominathan, L.,  Insulate your heart from cardiac diseases with Helicobacter Pyroli vaccine CTB-UE: CTB-UE vaccine-based Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients: CTB-UE vaccine increases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes via down-regulation of its target gene, 28/July/2018, 7.52 pm,  Genome-2-BioMedicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at info@genomediscovery.org

Comments are closed.